Showing 141 - 160 results of 27,826 for search '(( x a decrease ) OR ( 50 ((((we decrease) OR (mean decrease))) OR (nn decrease)) ))', query time: 0.95s Refine Results
  1. 141
  2. 142
  3. 143
  4. 144

    Depletion of xBMAL1 or xNOCTURNIN results in smaller, disorganized somites with disrupted somite boundaries. by Kristen L. Curran (95520)

    Published 2014
    “…Somites injected with either <i>xBmal1</i> MO (1 ng) or <i>xNocturnin</i> MO (1 ng) showed a significant decrease in somite area (*) when compared to the control MO (1 ng). …”
  5. 145
  6. 146

    Discovery of Betulinic Acid Derivatives as Potent Intestinal Farnesoid X Receptor Antagonists to Ameliorate Nonalcoholic Steatohepatitis by Chenlu Zhang (508309)

    Published 2022
    “…Evidence showed that intestinal FXR antagonism exhibited remarkable metabolic improvements in mice. Herein, we developed a series of betulinic acid derivatives as potent intestinal FXR antagonists, and <b>F6</b> was identified as the most potent one with an IC<sub>50</sub> at 2.1 μM. …”
  7. 147

    Discovery of Betulinic Acid Derivatives as Potent Intestinal Farnesoid X Receptor Antagonists to Ameliorate Nonalcoholic Steatohepatitis by Chenlu Zhang (508309)

    Published 2022
    “…Evidence showed that intestinal FXR antagonism exhibited remarkable metabolic improvements in mice. Herein, we developed a series of betulinic acid derivatives as potent intestinal FXR antagonists, and <b>F6</b> was identified as the most potent one with an IC<sub>50</sub> at 2.1 μM. …”
  8. 148
  9. 149

    Decreased axonal mitochondrial length in cultured 5xFAD mouse neurons. by Lu Wang (45927)

    Published 2016
    “…<p><b>(A)</b> 5xFAD mouse neurons demonstrated significantly decreased axonal mitochondrial length in comparison to nonTg neurons. …”
  10. 150
  11. 151

    Gene ontology biological processes overrepresented among genes exhibiting decreased expression in human psoriasis. by William R. Swindell (175427)

    Published 2011
    “…<p>A total of 3540 transcripts were identified as significantly decreased in psoriatic plaques obtained from human patients relative to normal skin obtained from control subjects (FDR-adjusted P<0.05 and log<sub>2</sub>-transformed fold-change less than -0.50). …”
  12. 152
  13. 153
  14. 154
  15. 155
  16. 156
  17. 157
  18. 158
  19. 159
  20. 160